吉林做个包皮手术能花多钱啊吉林哪家切包皮的医院效果好,吉林那家治疗包皮过长的医院好,吉林专业看包皮过长哪家比较好,吉林男科医院切包皮多少钱,吉林那个医院对早泄治疗比较,吉林一般割包皮大约得用多少钱,吉林治疗前列腺疾病哪家医院好

PORTLAND, Ore. (AP) — Journalists have been covering protests in Portland, Oregon, for three months. But in the chaos, some have been injured or arrested. Whether they are from major media outlets, freelancers, or self-proclaimed "citizen journalists," reporters say they're doing their job and law enforcement is hindering that work. Police say protesters have masqueraded as journalists and then set fires or thrown fireworks, making it a struggle to figure out who's a real reporter during the pandemonium. Journalists typically wear clothing that says "press" and has badges that clearly identify them as reporters. 627

Prescription drug ads are on every channel, and with them come the laundry list of side effects tacked on at the end of every TV spot. Now, in addition to listing those side effects, you could soon be hearing about the costs.A new proposal from the Trump administration would force manufacturers to state a drug's list price in any TV advertisement.It was a goal first laid out by Human and Health Services Secretary Alex Azar back in May."If we wanna have a real market for drugs, why not have them disclose their prices in the ads too?” asked Azar. “Consumers would have more balanced info and companies would have incentives for setting their prices…"Experts on drug pricing, like John Hopkins University's Gerard Anderson, say it’s about time."If you’re buying a TV, they'll tell you what a TV costs. If the grocery store’s having a sale, they’ll say how much oranges cost. This is something that should be and is just long overdue in the pharma industry,” Anderson says.Pharmaceutical companies have pushed back via their trade group, which said that posting prices on TV could be "misleading or confusing.” Their proposal was to, instead, tell consumers that pricing information could be found on the drug's website."The problem is that most of us would never go to their website to look up that information,” Anderson explains. “And the FDA would have to monitor closely the info on their site and that could change daily. So, it’s really not a viable option."The proposal will be open for public comment for 60 days, and even if it goes into effect after that, industry experts say they're likely to face many legal challenges from the pharmaceutical industry. 1676

President Donald Trump on Friday morning defended his tariffs against China despite market concerns, at one point saying, "we've already lost the trade war."The President took to Twitter and a radio interview to make his case after he threatened tariffs on 0 billion more in Chinese goods."We've already lost the trade war. We don't have a trade war. We've already lost," Trump told WABC radio, noting the US trade deficit with China and the country's theft of US intellectual property. 497

President Donald Trump remains in the hospital as he's being treated for COVID-19.His doctors today saying he’s in good spirits and has been fever free today, they also say he’s been treated with two different drugs. What are they and how do they work together?We went to a medical expert to try to get some clarity.“About 48 hours ago the president received a special antibody therapy directed against the coronavirus, working closely with the companies and monitoring him,” said Navy Commander Dr. Sean Conley. “Yesterday he received Remdesivir, and the plan is to continue a five-day treatment course for Remdesivir.”What is Remdesivir?Dr. Mangala Narasimhan, who’s been at Northwell Health for 13 years and has treated hundreds of COVID-19 patients explains.“Remdesivir is an anti-viral agent and it attacks the virus with hopes of making it less lethal and deadly," she said. "If you give Remdesivir early in the course before patients are really sick, you can prevent them from progressing on to a higher level of illness.”Doctors have recently been using the anti-viral drug on COVID-19 patients, but not the antibody cocktail produced by Regeneron Pharmaceuticals the president is also taking, because it hasn’t been FDA-approved.“Basically what your body does when it sees a virus it produces an antibody, so this is taking an antibody that was produced and cloning it so that produced in higher levels and giving it directly to you,” said Dr. Narasimhan. "The anti-viral cocktail is new, started developing in June, is not FDA-approved but they got it through a compassionate use for the president. We're not sure what side effects are.”The hope is that both treatments together will slow down the progression of the president’s coronavirus but it’s still unclear how his age, weight and the new drug waiting for FDA-approval will play into his recovery.“The two together are unknown for sure,” Dr. Narasimhan said. “The plus is you’ll stop the progression of COVID-19.”The president’s doctors say they are monitoring him closely not just for any COVID-19 complications but also for any effects the treatments may have on him.This story was first reported by Jennifer Bisram at PIX11 in New York, New York. 2224

President Donald Trump again broke with his top public health experts Monday and said that he believed that a COVID-19 vaccine would be approved "by the end of October."Trump made the statement during an interview on "Fox & Friends" Monday morning.When asked which vaccine would be approved first, Trump noted that Pfizer's vaccine candidate was doing "very well," and also listed several other candidates, including those made by Johnson & Johnson, Moderna and AstraZeneca.Top health officials in the Trump administration have said that it likely won't be until the end of the year that a vaccine will be approved for Emergency Use Authorization. Earlier this month, Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases, said that vaccine authorization won't come until after election day because trials likely won't be filled until the end of September, and the leading candidates require two shots that need to be taken at least 28 days apart.Earlier this month, several large drugmakers signed a open letter that promised that the companies would not bow to political pressure to approve a vaccine before it was scientifically proven to be safe and effective.Last week, the federal government released a "playbook" for the roll-out of a COVID-19 vaccine, which noted that essential workers, health care professionals and "vulnerable groups" would receive the vaccine first. Fauci has warned that Americans likely won't return to "normality" until the middle of 2021.The vaccination campaign faces an uphill battle from a skeptical public. An AP poll taken in May found only about half of those polled said they would get a COVID-19 vaccine. Experts say at least 70% of Americans need to be vaccinated or have immunity from a previous contraction in order to protect the country from the virus. 1839